BDBM405223 1-(4-(5-acetamido-1,3,4-thiadiazol-2- yl)-2-fluorobutyl)-N-((4- (trifluoromethyl)pyridin-2-yl)methyl)- 1H-1,2,3-triazole-4-carboxamide::US10344025, Example 567::US11370786, Example 567

SMILES CC(=O)Nc1nnc(CCC(F)Cn2cc(nn2)C(=O)NCc2cc(ccn2)C(F)(F)F)s1

InChI Key InChIKey=IKOFAQDXZHGSRC-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 405223   

TargetGlutaminase kidney isoform, mitochondrial(Human)
University Of Texas

US Patent
LigandPNGBDBM405223(1-(4-(5-acetamido-1,3,4-thiadiazol-2- yl)-2-fluoro...)
Affinity DataIC50: 100nMAssay Description:The inhibition of purified recombinant human GAC by varying concentrations of inhibitors is assessed via a dual-coupled enzymatic assay. The glutamat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/25/2022
Entry Details
US Patent

TargetGlutaminase kidney isoform, mitochondrial(Human)
University Of Texas

US Patent
LigandPNGBDBM405223(1-(4-(5-acetamido-1,3,4-thiadiazol-2- yl)-2-fluoro...)
Affinity DataIC50: 100nMAssay Description:The inhibition of purified recombinant human GAC by varying concentrations of inhibitors is assessed via a dual-coupled enzymatic assay. The glutamat...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2020
Entry Details
US Patent